DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms. .. Read more
Durect President & CEO: James E. Brown

President & CEO

James E. Brown

CEO Approval Rating

87/100

1998

PublicIndependent CompanyNASDAQDRRX

28342836 NAICS listing
Annual Revenue
$2M
Employees
80
Funding
$84M

Durect Competitors

1Recro Pharma
2Semnur Pharmaceuticals
3Innocoll
4Purdue Pharma
5Endo
6Intarcia
7Zosano Pharma
8Heron
9Iroko
10Zogenix

Trending Companies